Proceedings of the 19 th Otorhinolaryngology head and neck surgery national congress (PERHATIKL 2022)

Prevalence of Chronic Rhinositis with SARS-CoV-2 Infection in Rhinology-Allergy Clinic Hasan Sadikin General Hospital

Authors
Sinta Sari Ratunanda1, *, Sania Taufik Alkatirie1, Teti H. S. Madiadipoera1
1Departement of Ear, Nose, Throat, and Head and Neck Surgery, Dr. Hasan Sadikin General Hospital, Bandung, Indonesia
*Corresponding author.
Corresponding Author
Sinta Sari Ratunanda
Available Online 31 October 2023.
DOI
10.2991/978-94-6463-280-4_58How to use a DOI?
Keywords
Chronic Rhinosinusitis; COVID-19; EPOS 2020; Anosmia
Abstract

Introduction: Chronic rhinosinusitis (CRS) defined as the inflammation of the nasal lining and sinuses, presenting with persistent symptoms such as nasal congestion or a runny nose for a duration exceeding twelve weeks. The management of CRS in COVID-19 pandemic era follows the guidelines provided by EPOS 2020. Notably, symptoms like anosmia or hyposmia and ageusia are indicative of a COVID-19 infection. Purpose: This research purposes is to address the prevalence of CRS patients and COVID-19 and manifestation of COVID-19 in CRS patients from March 2020 – August 2021 at the ORL-HNS Allergy Rhinology Clinic, RSHS. Methods: This research employs a cross-sectional design, focusing on describing and observing various aspects of the subject under investigation. This study used secondary data from telephone interviews and a questionnaire administered to CRS patients. Results: 160 respondents are included in the inclusion criteria, with the majority being male (92 or 57.5%) and an average age of 37.5±17.2 years. The prevalence of COVID-19 in CRS patients during the study period was 28 (19.6%), with most CRS cases being without nasal polyps (46.4%). The most prevalent manifestation of COVID-19 found in CRS patients were elevated temperature (18 or 72%), anosmia (13 or 52%), followed by nasal congestion (9 or 36%). Conclusion: The prevalence of COVID-19 in CRS patients during the March 2020 – August 2021 period was 28 (17.5%). The clinical picture of CRS patients who experienced COVID-19 was that the symptoms were mostly mild, and the most common were anosmia, fever, and nasal congestion.

Copyright
© 2023 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Download article (PDF)

Volume Title
Proceedings of the 19 th Otorhinolaryngology head and neck surgery national congress (PERHATIKL 2022)
Series
Advances in Health Sciences Research
Publication Date
31 October 2023
ISBN
10.2991/978-94-6463-280-4_58
ISSN
2468-5739
DOI
10.2991/978-94-6463-280-4_58How to use a DOI?
Copyright
© 2023 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Cite this article

TY  - CONF
AU  - Sinta Sari Ratunanda
AU  - Sania Taufik Alkatirie
AU  - Teti H. S. Madiadipoera
PY  - 2023
DA  - 2023/10/31
TI  - Prevalence of Chronic Rhinositis with SARS-CoV-2 Infection in Rhinology-Allergy Clinic Hasan Sadikin General Hospital
BT  - Proceedings of the 19 th Otorhinolaryngology head and neck surgery national congress (PERHATIKL 2022)
PB  - Atlantis Press
SP  - 343
EP  - 348
SN  - 2468-5739
UR  - https://doi.org/10.2991/978-94-6463-280-4_58
DO  - 10.2991/978-94-6463-280-4_58
ID  - Ratunanda2023
ER  -